Schmidtke M - Search Results

1

Development of novel potent orally bioavailable oseltamivir derivatives active against resistant influenza A.

Schade D, Kotthaus J, Riebling L, Kotthaus J, Müller-Fielitz H, Raasch W, Koch O, Seidel N, Schmidtke M, Clement B. Schade D, et al. Among authors: schmidtke m. J Med Chem. 2014 Feb 13;57(3):759-69. doi: 10.1021/jm401492x. Epub 2014 Feb 3. J Med Chem. 2014. PMID: 24422530

2

Antiviral potential and molecular insight into neuraminidase inhibiting diarylheptanoids from Alpinia katsumadai.

Grienke U, Schmidtke M, Kirchmair J, Pfarr K, Wutzler P, Dürrwald R, Wolber G, Liedl KR, Stuppner H, Rollinger JM. Grienke U, et al. Among authors: schmidtke m. J Med Chem. 2010 Jan 28;53(2):778-86. doi: 10.1021/jm901440f. J Med Chem. 2010. PMID: 20014777

3

Novel neuraminidase inhibitors: identification, biological evaluation and investigations of the binding mode.

Kirchmair J, Rollinger JM, Liedl KR, Seidel N, Krumbholz A, Schmidtke M. Kirchmair J, et al. Among authors: schmidtke m. Future Med Chem. 2011 Mar;3(4):437-50. doi: 10.4155/fmc.10.292. Future Med Chem. 2011. PMID: 21452980

4

Computer-guided approach to access the anti-influenza activity of licorice constituents.

Grienke U, Braun H, Seidel N, Kirchmair J, Richter M, Krumbholz A, von Grafenstein S, Liedl KR, Schmidtke M, Rollinger JM. Grienke U, et al. Among authors: schmidtke m. J Nat Prod. 2014 Mar 28;77(3):563-70. doi: 10.1021/np400817j. Epub 2013 Dec 6. J Nat Prod. 2014. PMID: 24313801 Free PMC article.

5

Within-host influenza dynamics: a small-scale mathematical modeling approach.

Manchanda H, Seidel N, Krumbholz A, Sauerbrei A, Schmidtke M, Guthke R. Manchanda H, et al. Among authors: schmidtke m. Biosystems. 2014 Apr;118:51-9. doi: 10.1016/j.biosystems.2014.02.004. Epub 2014 Mar 11. Biosystems. 2014. PMID: 24614233

6

Hemagglutinin 222D/G polymorphism facilitates fast intra-host evolution of pandemic (H1N1) 2009 influenza A viruses.

Seidel N, Sauerbrei A, Wutzler P, Schmidtke M. Seidel N, et al. Among authors: schmidtke m. PLoS One. 2014 Aug 27;9(8):e104233. doi: 10.1371/journal.pone.0104233. eCollection 2014. PLoS One. 2014. PMID: 25162520 Free PMC article.

7

Zanamivir Amidoxime- and N-Hydroxyguanidine-Based Prodrug Approaches to Tackle Poor Oral Bioavailability.

Schade D, Kotthaus J, Riebling L, Kotthaus J, Müller-Fielitz H, Raasch W, Hoffmann A, Schmidtke M, Clement B. Schade D, et al. Among authors: schmidtke m. J Pharm Sci. 2015 Sep;104(9):3208-19. doi: 10.1002/jps.24508. Epub 2015 Jun 2. J Pharm Sci. 2015. PMID: 26037932

8

Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses.

Makarov VA, Braun H, Richter M, Riabova OB, Kirchmair J, Kazakova ES, Seidel N, Wutzler P, Schmidtke M. Makarov VA, et al. Among authors: schmidtke m. ChemMedChem. 2015 Oct;10(10):1629-34. doi: 10.1002/cmdc.201500304. Epub 2015 Aug 10. ChemMedChem. 2015. PMID: 26260222 Free PMC article.

9

Platform for determining the inhibition profile of neuraminidase inhibitors in an influenza virus N1 background.

Hoffmann A, Schade D, Kirchmair J, Clement B, Sauerbrei A, Schmidtke M. Hoffmann A, et al. Among authors: schmidtke m. J Virol Methods. 2016 Nov;237:192-199. doi: 10.1016/j.jviromet.2016.09.014. Epub 2016 Sep 19. J Virol Methods. 2016. PMID: 27659246

10

Binding and Proton Blockage by Amantadine Variants of the Influenza M2_WT and M2_S31N Explained.

Tzitzoglaki C, Wright A, Freudenberger K, Hoffmann A, Tietjen I, Stylianakis I, Kolarov F, Fedida D, Schmidtke M, Gauglitz G, Cross TA, Kolocouris A. Tzitzoglaki C, et al. Among authors: schmidtke m. J Med Chem. 2017 Mar 9;60(5):1716-1733. doi: 10.1021/acs.jmedchem.6b01115. Epub 2017 Feb 15. J Med Chem. 2017. PMID: 28107633 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page